Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy
- 1 October 1979
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 67 (4) , 583-589
- https://doi.org/10.1016/0002-9343(79)90238-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- VARIABLE RESPONSE TO LONG-TERM 1α-HYDROXYCHOLECALCIFEROL IN HÆMODIALYSIS OSTEODYSTROPHYThe Lancet, 1976
- CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1976
- Vitamin D and the KidneyNephron, 1975
- 1,25-DihydroxycholecalciferolArchives of internal medicine (1960), 1974
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL ON CALCIUM ABSORPTION, MUSCLE WEAKNESS, AND BONE DISEASE IN CHRONIC RENAL FAILUREThe Lancet, 1974
- Bone Crystal Maturation in Renal Osteodystrophy in HumansJournal of Clinical Investigation, 1974
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- Arrest of Hyperparathyroid Bone Disease with Dihydrotachysterol in Patients Undergoing Chronic HemodialysisAnnals of Internal Medicine, 1970
- A new method for determining micro quantities of calcium in biological materialsAnalytical Biochemistry, 1967
- STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM WITH SPECIAL REFERENCE TO PATHOGENESIS AND EFFECTS OF DIHYDROTACHYSTEROL (A.T.10) AND IRONMedicine, 1943